tiprankstipranks
Immucell Corp. (ICCC)
NASDAQ:ICCC
Holding ICCC?
Track your performance easily

Immucell (ICCC) Financial Statements

70 Followers

Immucell Financial Overview

Immucell's market cap is currently ―. The company's EPS TTM is $-0.485; its P/E ratio is -7.41; Immucell is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 6.01M$ 5.47M$ 7.26M$ 5.10M$ 5.40M
Gross Profit$ 1.58M$ 1.23M$ 2.30M$ 1.26M$ 1.27M
EBIT$ -556.21K$ -1.39M$ -290.52K$ -975.46K$ -803.84K
EBITDA$ 129.72K$ -706.13K$ 386.98K$ -290.48K$ -103.43K
Net Income Common Stockholders$ -701.69K$ -1.53M$ -437.87K$ -1.14M$ -940.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 1.32M$ 960.35K$ 978.74K$ 1.99M
Total Assets$ 44.45M$ 41.86M$ 43.05M$ 43.81M$ 44.55M
Total Debt$ 15.53M$ 15.84M$ 16.27M$ 16.69M$ 16.68M
Net Debt$ 15.53M$ 14.51M$ 15.31M$ 15.71M$ 14.69M
Total Liabilities$ 18.04M$ 18.40M$ 18.41M$ 18.82M$ 18.53M
Stockholders Equity$ 26.41M$ 23.46M$ 24.64M$ 24.99M$ 26.01M
Cash Flow-
Free Cash Flow$ -727.74K$ 475.54K$ 348.15K$ -689.29K$ -928.27K
Operating Cash Flow$ -639.33K$ 581.78K$ 418.50K$ -723.07K$ -507.75K
Investing Cash Flow$ -88.41K$ -106.24K$ -70.36K$ 33.78K$ -533.26K
Financing Cash Flow$ 3.21M$ -111.60K$ -366.54K$ -321.43K$ 1.58M
Currency in USD

Immucell Earnings and Revenue History

Immucell Debt to Assets

Immucell Cash Flow

Immucell Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis